IPIC 2025 – International Primary Immunodeficiencies Congress

Kedrion, a partner of Magna Pharmacija, organized a symposium on the topic: “Secondary immunodeficiencies in hematological malignancies”, which was also attended by representatives of Magna Pharma. IPIC 2025 (International Primary Immunodeficiencies Congress) is the leading international congress dedicated to primary immunodeficiencies, bringing together experts in the field of immunology, hematology and related disciplines. The congress provides a platform for the exchange of the latest scientific and clinical achievements, with a focus on advancing diagnostics, therapeutic approaches and long-term care of patients with primary immunodeficiencies. IPIC2025, which took place this year in Prague from 05-07.11, encourages interdisciplinary collaboration and the application of innovations in clinical practice.